At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 172 enrolled
Drug / intervention
T-Pred +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Study of T-PRED(TM) Compared to Pred Forte(R) II
In Brief
A Phase 3 clinical trial evaluating T-Pred and Pred Forte for Cataract. Completed, enrolled 172 participants across 1 site.
Detailed Summary
Study of T-PRED(TM) Compared to Pred Forte(R)
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCataract
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartFeb 2009
First PostedMar 2009
Primary CompletionAug 2009
TodayJul 2026
First PostedMar 2, 2009
Enrollment StartFeb 1, 2009
Primary CompletionAug 1, 2009
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 17.3 years ago
Interventions
T-Preddrug
sterile ophthalmic solution
Pred Fortedrug
sterile ophthalmic solution